NOVN.SW vs. VAPX.L

Last updated Jun 5, 2026

NOVN.SW (Novartis AG) is a stock, while VAPX.L (Vanguard FTSE Developed Asia Pacific ex Japan UCITS ETF Distributing) is Asia Pacific Equities fund tracking the MSCI AC Asia Pac Ex JPN NR USD. Over the past 10 years, NOVN.SW returned 9.98%/yr vs 9.64%/yr for VAPX.L. At a 0.36 correlation, their price movements are largely independent.

Performance

NOVN.SW vs. VAPX.L - Performance Comparison

The chart below illustrates the hypothetical performance of a CHF 10,000 investment in Novartis AG (NOVN.SW) and Vanguard FTSE Developed Asia Pacific ex Japan UCITS ETF Distributing (VAPX.L). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

NOVN.SW is traded in CHF, while VAPX.L is traded in GBP. To make them comparable, the VAPX.L values have been converted to CHF using the latest available exchange rates.

Returns By Period

In the year-to-date period, NOVN.SW achieves a 8.91% return, which is significantly lower than VAPX.L's 40.40% return. Both investments have delivered pretty close results over the past 10 years, with NOVN.SW having a 9.98% annualized return and VAPX.L not far behind at 9.64%.

NOVN.SW

• 1D: 2.04%
• 1M: 2.19%
• YTD: 8.91%
• 6M: 11.93%
• 1Y: 22.96%
• 3Y*: 14.41%
• 5Y*: 12.76%
• 10Y*: 9.98%

VAPX.L

• 1D: 0.65%
• 1M: 0.70%
• YTD: 40.40%
• 6M: 43.37%
• 1Y: 65.38%
• 3Y*: 20.02%
• 5Y*: 8.07%
• 10Y*: 9.64%

*Multi-year figures are annualized to reflect compound growth (CAGR)

NOVN.SW vs. VAPX.L - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
NOVN.SW Novartis AG	8.91%	27.98%	8.44%	11.93%	8.75%	-0.11%	-5.39%	28.50%	6.51%	16.04%
VAPX.L Vanguard FTSE Developed Asia Pacific ex Japan UCITS ETF Distributing	40.40%	23.42%	2.37%	-0.42%	-10.96%	3.88%	8.82%	15.38%	-13.86%	26.24%

Correlation

The correlation between NOVN.SW and VAPX.L is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.07
Correlation (3Y) Calculated over the trailing 3-year period	0.11
Correlation (5Y) Calculated over the trailing 5-year period	0.16
Correlation (10Y) Calculated over the trailing 10-year period	0.30
Correlation (All Time) Calculated using the full available price history since May 22, 2013	0.36

Over the past year, the correlation between NOVN.SW and VAPX.L has dropped to 0.07 - well below their long-term average of 0.36, suggesting their price drivers have been diverging.

Return for Risk

NOVN.SW vs. VAPX.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NOVN.SW

NOVN.SW Risk / Return Rank: 75
NOVN.SW Sharpe Ratio Rank: 79
NOVN.SW Sortino Ratio Rank: 72
NOVN.SW Omega Ratio Rank: 72
NOVN.SW Calmar Ratio Rank: 77
NOVN.SW Martin Ratio Rank: 77

VAPX.L

VAPX.L Risk / Return Rank: 93
VAPX.L Sharpe Ratio Rank: 95
VAPX.L Sortino Ratio Rank: 92
VAPX.L Omega Ratio Rank: 94
VAPX.L Calmar Ratio Rank: 91
VAPX.L Martin Ratio Rank: 91

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NOVN.SW vs. VAPX.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Novartis AG (NOVN.SW) and Vanguard FTSE Developed Asia Pacific ex Japan UCITS ETF Distributing (VAPX.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	NOVN.SW	VAPX.L	Difference
Sharpe ratio: Return per unit of total volatility	1.34	2.98	-1.64
Sortino ratio: Return per unit of downside risk	1.80	3.69	-1.89
Omega ratio: Gain probability vs. loss probability	1.24	1.54	-0.30
Calmar ratio: Return relative to maximum drawdown	2.29	5.55	-3.25
Martin ratio: Return relative to average drawdown	5.53	19.66	-14.13
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

NOVN.SW vs. VAPX.L - Sharpe Ratio Comparison

The current NOVN.SW Sharpe Ratio is 1.34, which is lower than the VAPX.L Sharpe Ratio of 2.98. The chart below compares the historical Sharpe Ratios of NOVN.SW and VAPX.L, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	NOVN.SW	VAPX.L	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.34	2.98	-1.64
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.72	0.45	+0.27
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.55	0.51	+0.04
Sharpe Ratio (All Time) Calculated using the full available price history	0.48	0.33	+0.15

Drawdowns

NOVN.SW vs. VAPX.L - Drawdown Comparison

The maximum NOVN.SW drawdown since its inception was -42.25%, which is greater than VAPX.L's maximum drawdown of -37.64%. Use the drawdown chart below to compare losses from any high point for NOVN.SW and VAPX.L.

Drawdown Indicators

	NOVN.SW	VAPX.L	Difference
Max Drawdown Largest peak-to-trough decline	-42.25%	-37.64%	-4.61%
Max Drawdown (1Y) Largest decline over 1 year	-10.78%	-11.72%	+0.94%
Max Drawdown (3Y) Largest decline over 3 years	-16.86%	-21.14%	+4.28%
Max Drawdown (5Y) Largest decline over 5 years	-16.86%	-28.00%	+11.14%
Max Drawdown (10Y) Largest decline over 10 years	-24.11%	-37.64%	+13.53%
Current Drawdown Current decline from peak	-8.53%	-8.43%	-0.10%
Average Drawdown Average peak-to-trough decline	-11.40%	-9.67%	-1.73%
Ulcer Index Depth and duration of drawdowns from previous peaks	4.43%	3.32%	+1.11%

Volatility

NOVN.SW vs. VAPX.L - Volatility Comparison

The current volatility for Novartis AG (NOVN.SW) is 6.01%, while Vanguard FTSE Developed Asia Pacific ex Japan UCITS ETF Distributing (VAPX.L) has a volatility of 11.93%. This indicates that NOVN.SW experiences smaller price fluctuations and is considered to be less risky than VAPX.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NOVN.SW	VAPX.L	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.01%	11.93%	-5.92%
Volatility (6M) Calculated over the trailing 6-month period	13.12%	19.29%	-6.17%
Volatility (1Y) Calculated over the trailing 1-year period	18.53%	21.91%	-3.38%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	17.81%	17.88%	-0.07%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	18.23%	18.95%	-0.72%

Dividends

NOVN.SW vs. VAPX.L - Dividend Comparison

NOVN.SW's dividend yield for the trailing twelve months is around 3.19%, more than VAPX.L's 1.91% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
NOVN.SW Novartis AG	3.19%	3.19%	3.72%	3.77%	3.91%	3.94%	3.72%	3.27%	3.98%	3.98%	4.35%	3.58%
VAPX.L Vanguard FTSE Developed Asia Pacific ex Japan UCITS ETF Distributing	1.91%	2.70%	3.47%	3.53%	4.32%	3.51%	2.08%	3.39%	3.52%	3.10%	2.71%	3.49%

Frequently Asked Questions

Can I hold both NOVN.SW and VAPX.L in my portfolio?

NOVN.SW and VAPX.L have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.